Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,926,387 Continuous or semi-continuous freezing coagulation method for aqueous polymer dispersions
The present invention relates to a continuous or semi-continuous freeze coagulation process for aqueous polymer dispersions, wherein said process comprises a...
US-9,926,386 Living radical polymerization catalyst, and polymer production method using same
An object of the present invention is to provide a living radical polymerization catalyst that is excellent in terms of safety and cost, and is applicable to...
US-9,926,385 Method for producing water-soluble cellulose ether having low degree of polymerization and method for producing...
Provided are a method for producing a water-soluble cellulose ether having a low degree of polymerization and enhanced whiteness, and the like. The method...
US-9,926,384 Regioselectively substituted cellulose esters produced in a tetraalkylammonium alkylphosphate ionic liquid...
This invention relates a cellulose solution comprising cellulose and at least one tetraalkylammonium alkylphosphate and processes to produce the cellulose...
US-9,926,383 Biocompatible three dimensional matrix for the immobilization of biological substances
The present invention relates to a method of producing a solid coated carrier carrying biological material. Furthermore, the invention relates to a solid coated...
US-9,926,382 Methods for the generation of multispecific and multivalent antibodies
The invention provides novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule and methods...
US-9,926,381 Antibodies targeting B-cell receptor complex membrane bound IGM and uses thereof
The present invention relates to monoclonal antibodies targeting the membrane bound IgM (mIgM) of the B-cell receptor complex found in B-cell lymphomas and...
US-9,926,380 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-1 in the context of HLA presentation on the surface of...
US-9,926,379 Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
The present invention relates to bispecific antibodies comprising at least one antigen binding site specific for DR5 and at least one antigen binding site...
US-9,926,378 Antibodies that bind OV064 and methods of use therefor
Antibodies and antigen-binding fragments of antibodies that bind OV064 are disclosed. The antibodies bind an extracellular domain of OV064. Some of the...
US-9,926,377 Anti-GPC3 antibodies and immunoconjugates
The invention provides anti-GPC3 antibodies and immunoconjugates and methods of using the same.
US-9,926,376 Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal...
US-9,926,375 Anti-endoglin antibodies and uses thereof
The present application relates to compositions of humanized and deimmunized anti-endoglin antibodies and antigen-binding fragments thereof. One aspect relates...
US-9,926,374 Human immune therapies using a CD27 agonist in combination with another immune agonist to treat cancer
Methods of inducing T cell proliferation and expansion in vivo for treating conditions wherein antigen-specific T cell immune response are therapeutically...
US-9,926,373 Human CD30 ligand antigen binding proteins
Provided are compositions and methods relating to human CD30L antigen binding proteins. Compositions described herein include: human CD30L antigen binding...
US-9,926,372 Methods and compositions for modulation of blood-neural barrier
Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy...
US-9,926,371 M-CSF specific monoclonal antibody and uses thereof
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a...
US-9,926,370 Antagonists of IL-6 to prevent or treat thrombosis
The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to...
US-9,926,369 Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the...
US-9,926,368 Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8
The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody...
US-9,926,367 Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTP.beta.), and uses thereof.
US-9,926,366 Methods of treating a hemolytic disorder comprising administering anti-properdin antibodies
A method of treating a hemolytic disorder in a subject in need thereof includes administering to the subject a therapeutically effective amount of an antibody...
US-9,926,365 Methods for reducing glycoprotein aggregation
The present invention provides methods for reducing glycoprotein aggregation by optimizing the number of O-linked glycosylation sites.
US-9,926,364 Chimeric human-llama antigens and methods of use
Provided are chimeric, camelid-human (e.g., llama-human) polypeptides comprising a first antigenic polypeptide portion and a second antigenic polypeptide...
US-9,926,363 Anti-campylobacter jejuni antibodies and uses therefor
Campylobacter jejuni is a leading cause of bacterial food-borne diseases in humans, ranging from acute diarrheal disease to neurological disorders. An isolated...
US-9,926,362 Immunoglobulin constant region Fc receptor binding agents
IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are...
US-9,926,361 Process for producing and purifying factor VIII and its derivatives
Disclosed is a method for producing proteins having factor VIII procoagulant activity in serum-free medium by in vitro culturing of mammalian cells, wherein the...
US-9,926,360 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
The present invention provides, in particular embodiments, for modified recombinant T cell receptor (TCR) ligands (RTLs) comprising a MHC class I or MHC class...
US-9,926,359 Optogenetic inhibition of overactive neuronal activity
This disclosure relates to recombinant proteins, vectors, and methods of treating neurological conditions by exposing neurons to an opsin and luciferase in the...
US-9,926,358 Water-soluble expression and purification method of human GCSF recombinant protein having biological activities
The present invention relates to a water-soluble expression and a purification method of a human granulocyte colony-stimulating factor (hGCSF) recombinant...
US-9,926,357 BMP-7 peptides and methods of use
The invention relates to truncated BMP-7 growth factors and variants thereof. The invention also relates to methods of making and using the truncated BMP-7...
US-9,926,356 Chimeric fibroblast growth factor 19 proteins and methods of use
The present invention relates to a chimeric protein that includes an N-terminus coupled to a C-terminus, where the N-terminus includes a portion of a paracrine...
US-9,926,354 Amyloid precursor protein (APP) based #-secretase inhibitor peptides, and methods of use
The present invention provides fusion peptides, compositions, methods and kits for treating, reducing the risk of, lessening the severity of, preventing, or...
US-9,926,353 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized...
The present invention is directed to polymerized products and compositions useful for the treatment and prevention of amyloid disease in a subject. The...
US-9,926,352 Chimeric dystrophin-VSV-G protein to treat dystrophinopathies
A chimeric protein that is a fusion construct of a series of functional domains is used to deliver a therapeutic agent to a human subject suffering from...
US-9,926,351 Extended recombinant polypeptides and compositions comprising same
The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (XTEN), isolated nucleic acids...
US-9,926,350 Targeting of chondroitin sulfate glycans
The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments...
US-9,926,349 Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the PFR1 protein of...
The present invention claims an isolated nucleotide sequence characterized by encoding the PFR1 protein of Leishmania infantum or a fragment thereof. This PFR1...
US-9,926,348 Method for producing fibroin-like protein
A method for producing a fibroin-like protein is described. A fibroin-like protein is produced by culturing Escherichia coli having a gene encoding the...
US-9,926,347 Methods for engineering sugar transporter preferences
Provided herein are compositions and methods useful for transporting xylose, arabinose and other monosaccharides, into a yeast cell.
US-9,926,346 Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof
Recombinant Mycobacteria (rMyc) which contain sequences encoding a heparin-binding hemagglutinin (HBHA) fusion protein are provided, as are methods of making...
US-9,926,345 Compositions and methods for treating or preventing Clostridium infection
Clostridium difficile is a leading cause of antibiotic-associated infection in hospitals worldwide. There is a need for a vaccine to Clostridium difficile that...
US-9,926,344 Stabilised proteins for immunising against Staphylococcus aureus
Elimination of disulphide bond formation of cysteine-containing S. aureus antigens enhances antigen stability. The invention provides variant forms of...
US-9,926,343 Mutant fragments of OspA and methods and uses relating thereto
The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a...
US-9,926,342 Recombinant VapA and VapC peptides and uses thereof
The present invention provides a recombinant protein comprising consecutive amino acids, the sequence of which is substantially identical to a sequence of amino...
US-9,926,341 Copolymers for protein precipitation
The present invention relates to the isolation of recombinant and/or biotherapeutic proteins for capture or clarification from cell culture fluid using...
US-9,926,340 NAD analogs and methods of using said NAD analogs in determining ribosylation of proteins with PARP mutants
The present disclosure provides NAD analogs of the formula: ##STR00001## wherein R.sub.1, n, and X.sub.1 are defined herein, useful for the identification...
US-9,926,339 Fluorine-containing silane compound
A novel fluorine-containing silane compound is provided. The fluorine-containing silane compound is capable of providing excellent water repellency and oil...
US-9,926,338 Carboxylic acid functional siloxanes of defined structure
Organopolysiloxanes bearing regularly spaced pendent carboxylic acid groups or salts thereof have a block polymer structure and are derived by the double...
US-9,926,337 Substituted asymmetric ureas as modulators of ghrelin receptor activity
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.